| Univariate | Multivariable | ||||
---|---|---|---|---|---|---|
 | Hazard ratio | 95% CI | p-Value | Hazard ratio | 95% CI | p-Value |
Baseline characteristics | Â | Â | Â | Â | Â | Â |
 Age ≥ 80 years | 1.33 | 0.90–1.97 | 0.152 | 1.33 | 0.84–2.12 | 0.219 |
 Sex, Female | 1.18 | 0.81–1.70 | 0.386 |  |  |  |
 BMI < 22 kg/m2 | 1.04 | 0.73–1.49 | 0.808 |  |  |  |
 ECOG PS of 0 | 0.46 | 0.21–0.66 | < 0.001 | 0.63 | 0.42–0.95 | 0.031 |
Tumor characteristics | Â | Â | Â | Â | Â | Â |
 Primary tumor sites, Gallbladder | 2.81 | 1.86–4.26 | < 0.001 | 2.00 | 1.28–3.11 | < 0.001 |
 Recurrence | 0.93 | 0.57–1.49 | 0.763 |  |  |  |
Laboratory values | Â | Â | Â | Â | Â | Â |
 NLR ≥ 2.6 | 1.63 | 1.15–2.33 | 0.007 | 1.76 | 1.18–2.61 | 0.005 |
 Albumin < 3.5 g/dL | 1.66 | 1.16–2.36 | 0.005 | 1.28 | 0.84–1.95 | 0.249 |
 CRP ≥ 1.0 mg/dL | 2.18 | 1.52–3.14 | < 0.001 | 1.79 | 1.17–2.73 | 0.007 |
 CEA ≥ 5.0 ng/mL | 2.25 | 1.56–3.24 | < 0.001 | 2.00 | 1.31–3.02 | 0.001 |
 CA 19 − 9 ≥ 37.0 ng/mL | 2.08 | 1.42–3.03 | < 0.001 | 1.10 | 0.71–1.67 | 0.666 |
Treatment | Â | Â | Â | Â | Â | Â |
 Biliary drainage | 0.70 | 0.49–1.00 | 0.053 |  |  |  |
 Combination therapy | 0.70 | 0.48–1.01 | 0.058 | 1.08 | 0.69–1.73 | 0.716 |
 Second-line chemotherapy | 0.61 | 0.43–0.88 | 0.007 |  |  |  |